K

Oxford Science Enterprises logo

Oxford Science Enterprises

Crunchbase
Pitchbook
Crunchbase

Deals on record

7

Common Fundraising Type

Equity

Mixergy logo
Mixergy

Smart hot water storage • Home energy solutions

Barclays Climate Ventures logo
Oxford Science Enterprises logo
Nesta logo
Kiko Ventures logo

Mixergy develops smart hot water storage and home energy solutions to enhance heating efficiency and sustainability.

Equity
$15.5M
03/10/2025
Article
Salience Labs logo
Salience Labs

Photonic solutions • AI datacenter connectivity

ICM HPQC Fund logo
Oxford Sciences Enterprises logo
Silicon Catalyst logo
Cambridge Innovation Capital logo

Salience Labs develops photonic solutions, specifically optical switches, to enhance AI datacenter connectivity.

Series A
$30M
02/07/2025
Article
Neu Health logo
Neu Health

AI-driven • Digital neurology

Oxford Science Enterprises logo
Cedars-Sinai Intellectual Property Company logo

Neu Health is a health-tech startup that develops an AI-driven digital neurology care platform to improve care for Parkinson’s disease and dementia through personalized, data-driven approaches.

Equity
$2M
01/29/2025
Article
FluoRok logo
FluoRok

Fluorinating reagents • Lithium hexafluorophosphate

Volta Energy Technologies logo
University of Oxford logo
Oxford Science Enterprises logo
Green Generation Fund logo

FluoRok develops safer and more sustainable fluorochemicals, including lithium hexafluorophosphate for lithium-ion batteries, using innovative technology that bypasses hazardous processes.

Equity
$10.3M
09/23/2024
Article
OQC logo
OQC

Quantum Computing • Compute-as-a-Service (QCaaS)

University of Tokyo Edge Capital logo
SBI Investment logo
Oxford Science Enterprises logo
OTIF logo

OQC provides quantum compute-as-a-service (QCaaS), developing and deploying enterprise-ready quantum computing platforms for global business applications.

Series B
$100M
11/27/2023
Article
Sitryx Therapeutics logo
Sitryx Therapeutics

Biopharmaceutical • Immunometabolism

GSK logo
SV Health Investors logo
Sofinnova Partners logo
Oxford Science Enterprises logo

Sitryx Therapeutics is a biopharmaceutical company that develops disease-modifying therapeutics for chronic autoimmune and inflammatory diseases by targeting and regulating cell metabolism.

Equity
$39M
09/27/2023
Article
AlveoGene logo
AlveoGene

Gene Therapy • Respiratory Diseases

University of Edinburgh logo
Oxford Science Enterprises logo
Harrington Discovery Institute at University Hospitals logo

AlveoGene is a UK-based biotech company that develops inhaled gene therapies for rare respiratory diseases, with an initial focus on alpha-1 antitrypsin deficiency disease.

Seed
Undisclosed
09/14/2023
Article